CDER Drug Safety Labeling Changes - 6/16/2022

Drug Safety-related Labeling Changes (SrLC) The SrLC database has been updated with the following approved drug safety labeling changes. Drug Name Active Ingredient Application Number Application Type Supplement Date Database Updated BYETTA EXENATIDE SYNTHETIC 021773 NDA 06/10/2022 06/15/2022 RUBRACA RUCAPARIB CAMSYLATE 209115 NDA 06/10/2022 06/14/2022 RYBELSUS SEMAGLUTIDE 213051 NDA 06/10/2022 06/15/2022 XULTOPHY 100/3.6 INSULIN DEGLUDEC; LIRAGLUTIDE 208583 BLA 06/10/2022 06/14/2022 Manage Subscriptions  |  Unsubscribe All  |  Help This email was sent to ooseims.archieves@blogger.com using GovDelivery Communications Cloud on behalf of: U.S. Food and Drug Administration ·  10903 New Hampshire Ave · Silver Spring, MD ·  20993-0002 ·  1-888-INFO-FDA